| 000 | 01362 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513102424.0 | ||
| 264 | 0 | _c19961106 | |
| 008 | 199611s 0 0 eng d | ||
| 022 | _a0002-9394 | ||
| 024 | 7 |
_a10.1016/s0002-9394(14)72124-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChaknis, M J | |
| 245 | 0 | 0 |
_aInflammatory opacities of the vitreous in rifabutin-associated uveitis. _h[electronic resource] |
| 260 |
_bAmerican journal of ophthalmology _cOct 1996 |
||
| 300 |
_a580-2 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xcomplications |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadverse effects |
| 650 | 0 | 4 |
_aEye Diseases _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluconazole _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aRifabutin _xadverse effects |
| 650 | 0 | 4 |
_aUveitis, Anterior _xchemically induced |
| 650 | 0 | 4 |
_aUveitis, Posterior _xchemically induced |
| 650 | 0 | 4 | _aVisual Acuity |
| 650 | 0 | 4 |
_aVitreous Body _xdrug effects |
| 700 | 1 | _aBrooks, S E | |
| 700 | 1 | _aMitchell, K T | |
| 700 | 1 | _aMarcus, D M | |
| 773 | 0 |
_tAmerican journal of ophthalmology _gvol. 122 _gno. 4 _gp. 580-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0002-9394(14)72124-5 _zAvailable from publisher's website |
| 999 |
_c8854872 _d8854872 |
||